Retifanlimab in patients with recurrent microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) endometrial cancer: Final results from the POD1UM-101 study (Cohort H)
Van Gorp, Toon; Division Of Gynaecological Oncology, University Hospitals Leuven, Leuven Cancer Institute, 3000 - Leuven/BE > Department Of Gynaecology
Language :
English
Title :
Retifanlimab in patients with recurrent microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) endometrial cancer: Final results from the POD1UM-101 study (Cohort H)